Science Explorer Interactive view Map
Company · Berlin · Germany

Mologen (Germany)

Research works
42
▼ 67% vs 2013–17
Citations
632
15.0 per fractional work
Top-10% rate
28.6%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Mologen (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Mologen (Germany) specialise in?

Where its research is concentrated relative to its size: Life Sciences takes 3.8× the share of its output that it takes of world research.

  1. Life SciencesDomain · 24.1 works3.8×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Mologen (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Innate Immunity, Immunity, Cancer Immunotherapy, Antigen Presentation, Dendritic Cells, Tumor Antigen, Gene Therapy and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Innate Immunity8▲ 54×3 topics
  2. Immunity8▲ 53×3 topics
  3. Cancer Immunotherapy7▲ 124×2 topics
  4. Antigen Presentation7▲ 162×2 topics
  5. Dendritic Cells7▲ 136×1 topic
  6. Tumor Antigen7▲ 192×1 topic
  7. Gene Therapy6▲ 49×3 topics
  8. Inflammation5▲ 5.2×7 topics
  9. Tumor Microenvironment5▲ 32×3 topics
  10. Pattern Recognition Receptors5▲ 76×2 topics
  11. Chemotherapy4▲ 15×7 topics
  12. Immune Checkpoint Blockade4▲ 188×1 topic
  13. PD-1 and PD-L14▲ 188×1 topic
  14. Immunotherapy4▲ 15×7 topics
  15. Innate Antiviral Responses4▲ 138×1 topic
  16. Toll-like Receptors4▲ 56×1 topic
  17. Targeted Therapy3▲ 28×4 topics
  18. RNA Interference2▲ 53×1 topic
  19. Tumor Regression2▲ 67×2 topics
  20. siRNA Delivery2▲ 79×1 topic
  21. Prognostic Factors2▲ 12×4 topics
  22. Epidemiology2▲ 1.25×14 topics
  23. Cancer2▲ 3.4×5 topics
  24. Clinical Trials2▲ 7.7×2 topics
  25. Tumor Targeting2▲ 32×2 topics
  26. Arginine Deprivation2▲ 94×1 topic
  27. Bacterial Therapy2▲ 94×1 topic
  28. NK Cell Recognition2▲ 39×1 topic
  29. Natural Killer Cells2▲ 39×1 topic
  30. Genomic Integration1▲ 31×2 topics
  31. Genomic Stability1▲ 34×2 topics
  32. Metastasis1▲ 9.0×2 topics
  33. AAV1▲ 45×1 topic
  34. Genomic Profiles1▲ 82×1 topic
  35. Small-Cell Lung Cancer1▲ 82×1 topic
  36. Viral Vectors1▲ 45×1 topic
  37. Resistance1▲ 23×2 topics
  38. Immune Response1▲ 4.0×6 topics
  39. Treatment1▲ 1.86×4 topics

Which research topics does Mologen (Germany) publish most on?

By volume in 2022–2025: Transportation Planning and Optimization, Transportation and Mobility Innovations, Urban Transport and Accessibility and Pesticide and Herbicide Environmental Studies.

  1. 1 Transportation Planning and Optimization Transportation 0 works
  2. 2 Transportation and Mobility Innovations Automotive Engineering 0 works
  3. 3 Urban Transport and Accessibility Transportation 0 works
  4. 4 Pesticide and Herbicide Environmental Studies Pollution 0 works
  5. 5 Weed Control and Herbicide Applications Plant Science 0 works
  6. 6 Allelopathy and phytotoxic interactions Plant Science 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.4%not open65.6%

World: 28% of research is openly available.

with international co-authors31.8%domestic only68.2%

World: 19% is written across borders.

How has Mologen (Germany)'s research output changed?

Output in 2018–2022 was 67% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.